Comparison of intravenous thrombolysis agents for acute ischemic stroke: a systematic review and network meta-analysis
Intravenous thrombolysis (IVT) is the most important treatment for acute ischemic stroke (AIS) patients within 4.5 h of symptom onset, but the lack of head-to-head trials prevents comparisons of the IVT agents’ efficacy and safety, posing challenges for the selection of the best IVT agent. We aimed to evaluate all...